Related Experiment Video
Updated: Feb 17, 2026

Isolation and Characterization of Mouse Primary Liver Sinusoidal Endothelial Cells
Published on: December 16, 2021
Pathological process of liver sinusoidal endothelial cells in liver diseases
Yao Ni1, Juan-Mei Li1, Ming-Kun Liu1
1Department of Infection, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China.
Insights
Liver sinusoidal endothelial cells (LSECs) play a key role in liver fibrosis and cirrhosis by producing angiogenic cytokines. Targeting LSEC angiogenesis offers a promising therapeutic strategy for liver disease treatment.
Area of Science:
- Hepatology
- Cell Biology
- Angiogenesis Research
Background:
- Cirrhosis, the severe stage of chronic liver injury, stems from liver fibrosis.
- Hepatitis B and C virus infections are common causes of cirrhosis.
- Excess extracellular matrix production, linked to liver sinusoidal endothelial cells (LSECs), drives fibrosis and cirrhosis.
Purpose of the Study:
- To highlight the role of LSEC angiogenic cytokines in liver fibrosis and cirrhosis.
- To focus on the formation and progression of liver fibrosis and cirrhosis.
- To detail LSEC angiogenesis inhibition and antiangiogenic therapies.
Main Methods:
- Review of literature on LSEC function in liver disease.
- Analysis of angiogenic cytokines secreted by LSECs.
- Examination of therapeutic strategies targeting LSEC angiogenesis.
Main Results:
- Damaged LSECs release factors like TGF-β and PDGF, activating hepatic stellate cells.
- LSEC-derived angiogenic cytokines are crucial at various stages of liver fibrosis and cirrhosis.
- Inhibition of LSEC angiogenesis presents a viable therapeutic approach.
Conclusions:
- Targeting LSECs holds significant therapeutic potential for liver diseases.
- Further research into LSEC mechanisms will advance anti-LSEC drug development.
- Understanding LSEC roles offers new diagnostic and treatment avenues for liver conditions.
Abstract:
Cirrhosis develops from liver fibrosis and is the severe pathological stage of all chronic liver injury. Cirrhosis caused by hepatitis B virus and hepatitis C virus infection is especially common. Liver fibrosis and cirrhosis involve excess production of extracellular matrix, which is closely related to liver sinusoidal endothelial cells (LSECs). Damaged LSECs can synthesize transforming growth factor-beta and platelet-derived growth factor, which activate hepatic stellate cells and facilitate the synthesis of extracellular matrix. Herein, we highlight the angiogenic cytokines of LSECs related to liver fibrosis and cirrhosis at different stages and focus on the formation and development of liver fibrosis and cirrhosis. Inhibition of LSEC angiogenesis and antiangiogenic therapy are described in detail. Targeting LSECs has high therapeutic potential for liver diseases. Further understanding of the mechanism of action will provide stronger evidence for the development of anti-LSEC drugs and new directions for diagnosis and treatment of liver diseases.
More Related Videos
08:38A Standardized Method for the Analysis of Liver Sinusoidal Endothelial Cells and Their Fenestrations by Scanning Electron Microscopy
Published on: April 30, 2015
08:41Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
Related Concept Videos
Liver Histology
Hepatocytes perform a variety of essential functions. They secrete...
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Hepatic Portal System
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...